113 related articles for article (PubMed ID: 897286)
1. [Pseudomonas maltophilia in cerebrospinal fluid samples. Isolation, identification and antibiograms of 4 strains].
Mulinas L; Lorente S; Borras R; Ferrer A; Sanchis-Bayarri Vaillant V
Rev Clin Esp; 1977 Jul 15-31; 146(1-2):31-4. PubMed ID: 897286
[No Abstract] [Full Text] [Related]
2. [Pseudomonas maltophilia infections].
Pintér M; Kántor M
Orv Hetil; 1974 Feb; 115(5):254-5. PubMed ID: 4839507
[No Abstract] [Full Text] [Related]
3. [Monitoring of antibiotic resistance in Ps. aeruginosa and in Ps. maltophilia in the Ospedale di Pordenone].
Chiaradia V; Santini GF
G Ital Chemioter; 1988; 35(1-3):23-5. PubMed ID: 3151487
[No Abstract] [Full Text] [Related]
4. In vitro activity of azithromycin as an antipseudomonal agent.
Mahapatra A; Mahapatra A; Padhi S; Mahapatro S; Ghosh SK
Indian J Pathol Microbiol; 2006 Oct; 49(4):634-5. PubMed ID: 17183885
[No Abstract] [Full Text] [Related]
5. [Pseudomonas paucimobilis infections. An analysis of 2 cases].
Sanchis-Bayarri Vailant V; Marcaida Benito G; Sanchis-Bayarri Bernal V; Ramos Martí JL
Rev Clin Esp; 1993 Apr; 192(7):353-4. PubMed ID: 8497747
[No Abstract] [Full Text] [Related]
6. [Isolation and identification of a strain of Pseudomonas putrefaciens].
Sanchis-Bayarri Vaillant V; Sanchis-Bayarri Lahoz V
Rev Clin Esp; 1981 Apr; 161(2):119-20. PubMed ID: 7280316
[No Abstract] [Full Text] [Related]
7. Significance and characterisation of pseudomonads from urinary tract specimens.
Taneja N; Meharwal SK; Sharma SK; Sharma M
J Commun Dis; 2004 Mar; 36(1):27-34. PubMed ID: 16295683
[TBL] [Abstract][Full Text] [Related]
8. [Pseudomonas: microbiological aspects and sensitivity to tobramycin and gentamycin].
Ceruti T; Bassi L; Biazzi E; Fasani AM; Pedroni P
Arch Sci Med (Torino); 1982; 139(4):463-5. PubMed ID: 6820271
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas maltophilia infections in man.
Gilardi GL
Am J Clin Pathol; 1969 Jan; 51(1):58-61. PubMed ID: 5766111
[No Abstract] [Full Text] [Related]
10. Use of Etest to assess synergy of antibiotic combinations against clinical isolates of Pseudomonas spp.
Fodor E; Hajdú E; Nagy E
Int J Antimicrob Agents; 2005 Feb; 25(2):183-4. PubMed ID: 15664494
[No Abstract] [Full Text] [Related]
11. In vitro susceptibility of Pseudomonas maltophilia to antimicrobial agents.
Igari J; Oguri T; Kosakai N
Jpn J Antibiot; 1986 Jan; 39(1):121-6. PubMed ID: 3702054
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas species Ve-2 septicemia.
Gómez Garcés JL; Aguado JM; Fernández-Clúa MA; Soriano F
Eur J Clin Microbiol; 1986 Apr; 5(2):168-9. PubMed ID: 3720740
[No Abstract] [Full Text] [Related]
13. Study of the incidence of Pseudomonas in gangrenous lesions and its sensitivity to antibiotics and to chemoterapics.
Brenciaglia MI; Cipriani P; Dainelli B; Mancini C
Antibiotica; 1977 Mar; 14(1):47-57. PubMed ID: 879717
[No Abstract] [Full Text] [Related]
14. Identification and distribution of Pseudomonas stutzeri in clinical material.
Holmes B
J Appl Bacteriol; 1986 May; 60(5):401-11. PubMed ID: 3522526
[TBL] [Abstract][Full Text] [Related]
15. [Pseudomonas maltophilia as an agent of infection in man (author's transl)].
Fritsche D; Lütticken R; Böhmer H
Zentralbl Bakteriol Orig A; 1974; 229(1):89-97. PubMed ID: 4155214
[No Abstract] [Full Text] [Related]
16. Pseudomonas cepacia in the West of Scotland.
Henderson A; Byatt ME
Health Bull (Edinb); 1974 May; 32(3):100-2. PubMed ID: 4418941
[No Abstract] [Full Text] [Related]
17. [Drug sensitivity of bacterial strains isolated from clinical specimens during the years 1987-1988].
Rafałowska K; Leszczyński P
Pol Tyg Lek; 1990 Sep 3-10; 45(36-37):732-5. PubMed ID: 2084629
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of aztreonam against Pseudomonas: epidemiological aspects.
Crotti D; Barbieri C; Cellie P; Fonzo G; Visintin F
Chemioterapia; 1987 Jun; 6(2 Suppl):107-8. PubMed ID: 3509364
[No Abstract] [Full Text] [Related]
19. [Characterization of a Chrysemonas luteola strain isolated from a healthy carrier and investigation of pathogenicity, virulence and antibiotic resistance factors through in vitro and in vivo studies].
Israil A; Balotescu C; Alexandru I
Bacteriol Virusol Parazitol Epidemiol; 2004; 49(1-2):43-7. PubMed ID: 16752751
[No Abstract] [Full Text] [Related]
20. [Clinico-microbiologic aspects of burns complicated by suppurative infection].
Znamenskiĭ VA; Litovchenko PP; Degtiar NV; Sitniakovskaia VS; Chernobrovyĭ NP
Khirurgiia (Mosk); 1989 Mar; (3):115-7. PubMed ID: 2724836
[No Abstract] [Full Text] [Related]
[Next] [New Search]
